ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36775
-0.01%
Bitcoin
60,778.57
-0.03%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Equillium Inc (EQ)

  7. Equillium Inc (EQ) News

EQ

Equillium (EQ)

Equillium Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EQ
DateTimeSourceHeadlineSymbolCompany
05/09/20243:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQEquillium Inc
05/09/20243:01PMBusiness WireEquillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical HighlightsNASDAQ:EQEquillium Inc
05/07/20247:00AMBusiness WireEquillium Announces Poster Presentation at the Annual Meeting of The American Association of ImmunologistsNASDAQ:EQEquillium Inc
04/03/20247:00AMBusiness WireEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EQEquillium Inc
04/01/20247:00AMBusiness WireEquillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus NephritisNASDAQ:EQEquillium Inc
03/25/20243:01PMBusiness WireEquillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical HighlightsNASDAQ:EQEquillium Inc
03/22/20247:00AMBusiness WireEquillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational ConferenceNASDAQ:EQEquillium Inc
03/08/20244:35PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EQEquillium Inc
03/08/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
02/23/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
02/23/20244:09PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EQEquillium Inc
02/22/20245:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
01/03/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
01/03/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
01/03/20245:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
12/21/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
12/21/20237:00AMBusiness WireEquillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac DiseaseNASDAQ:EQEquillium Inc
11/20/202310:23AMPR Newswire (US)EQ Bank Card launches in Québec as Carte Banque EQNASDAQ:EQEquillium Inc
11/20/202310:23AMPR Newswire (Canada)EQ Bank Card launches in Québec as Carte Banque EQNASDAQ:EQEquillium Inc
11/13/20238:00AMBusiness WireEquillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of RheumatologyNASDAQ:EQEquillium Inc
11/08/20233:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQEquillium Inc
11/08/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
11/08/20233:01PMBusiness WireEquillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:EQEquillium Inc
11/06/20237:00AMBusiness WireEquillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of NephrologyNASDAQ:EQEquillium Inc
10/19/20237:00AMBusiness WireEquillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of RheumatologyNASDAQ:EQEquillium Inc
10/16/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
10/16/20237:00AMBusiness WireEquillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics SymposiumNASDAQ:EQEquillium Inc
10/05/20234:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
10/05/20234:23PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EQEquillium Inc
10/03/20237:00AMBusiness WireEquillium to Host Analyst & Investor DayNASDAQ:EQEquillium Inc
 Showing the most relevant articles for your search:NASDAQ:EQ

Your Recent History

NASDAQ
RNAZ
TransCode Therapeutics
USOTC
FMCC
Federal Home Loan Mortgage (QB)
USOTC
PHIL
PHI (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
COOP
Mr Cooper
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
AXXA
Exxe (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
TPTW
TPT Global Tech (CE)
NASDAQ
SEV
Sono Group NV
USOTC
KEGS
1812 Brewing (PK)
USOTC
CGAC
Code Green Apparel (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved